Prevention of abnormal scarring in woundhealing

S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention

of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Researchers show an old law still holds for quirky quantum materials

This surprising result is important for understanding unconventional superconductors and other materials where electrons band together to act collectively. Long before researchers discovered the electron and its role in generating…

Straining memory leads to new computing possibilities

Researchers develop hybrid phase-change memristors that offer fast, low-power, and high-density computing memory.# By strategically straining materials that are as thin as a single layer of atoms, University of Rochester scientists have…

A patch of protection against Zika virus

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus. A prototype using The University of Queensland-developed and Vaxxas-commercialised high-density microarray patch…

Partners & Sponsors